The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Vorolanib (CM082), everolimus, and the combination in patients with pretreated metastatic renal cell carcinoma (CONCEPT study): A randomized, phase 2/3, double-blind, multi-center trial.
 
Jun Guo
No Relationships to Disclose
 
Xinan Sheng
No Relationships to Disclose
 
Dingwei Ye
No Relationships to Disclose
 
Zhisong He
No Relationships to Disclose
 
Ai-Ping Zhou
No Relationships to Disclose
 
Xin Yao
No Relationships to Disclose
 
Zengjun Wang
No Relationships to Disclose
 
Benkang Shi
No Relationships to Disclose
 
Xinhua Tu
No Relationships to Disclose
 
Yanqiao Zhang
No Relationships to Disclose
 
Chaohong He
No Relationships to Disclose
 
Cheng Fu
No Relationships to Disclose
 
Zhigang Ji
No Relationships to Disclose
 
Bo Yang
No Relationships to Disclose
 
Bin Wu
No Relationships to Disclose
 
Shukui Qin
No Relationships to Disclose
 
Zhiquan Hu
No Relationships to Disclose
 
Fang-Jian Zhou
No Relationships to Disclose
 
Jianming Guo
No Relationships to Disclose
 
Fenlai Tan
Employment - Betta Pharmaceuticals
Leadership - Betta Pharmaceuticals
Stock and Other Ownership Interests - Betta Pharmaceuticals